Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship
Original Article
Published on
Journal: European Journal of Clinical Microbiology & Infect [Category] COVID-19, MERS, SARS,
Journal: European Journal of Clinical Microbiology & Infect [Category] COVID-19, MERS, SARS,
[키워드] acute respiratory syndrome
Adequate
Admission
ampicillin/sulbactam
antibiotic
antibiotic stewardship
Antigen
Antimicrobial therapy
Aspergillus fumigatus
bacterial co-infection
bacterial co-infections
blood culture
caused
Characteristics
clinical
Co-infection
collected
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
Critically ill
Critically ill patient
critically ill patients
diagnostic
Diagnostic stewardship
Final
Follow-up
fungal
help
hospital
infectious complication
intensive care unit
investigation
Legionella pneumophila
Local
males
management
median
median age
microbial
outcome
pandemic
performed
prevalent
Prevent
Rate
regimen
required
respiratory viral
retrospective cohort study
Retrospective study
SARS-CoV-2
Spread
Streptococcus
supplementary material
therapeutic
university
urinary
use of antibiotics
[DOI] 10.1007/s10096-020-04063-8 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1007/s10096-020-04063-8 PMC 바로가기 [Article Type] Original Article